01 11Xtandi
02 3Xtandi Alliance Revenues
03 2Xtandi alliance revenues
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 838
2018 Revenue in Millions : 699
Growth (%) : 20
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 4,076
2019 Revenue in Millions : 3,460
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 4,451
2020 Revenue in Millions : 4,048
Growth (%) : 19
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 1,024
2019 Revenue in Millions : 838
Growth (%) : 22
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 1,185
2020 Revenue in Millions : 1,024
Growth (%) : 16
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 5,038
2021 Revenue in Millions : 4,511
Growth (%) : 12
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 1,198
2021 Revenue in Millions : 1,185
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 4,780
2022 Revenue in Millions : 5,038
Growth (%) : 7
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 1,191
2022 Revenue in Millions : 1,198
Growth (%) : -1
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 480
2014 Revenue in Millions : 1,207
Growth (%) : 151%
LOOKING FOR A SUPPLIER?
